학술논문
Pan-cancer identified ARPC1B as a promising target for tumor immunotherapy and prognostic biomarker, particularly in READ
Document Type
Article
Source
In Heliyon 15 April 2024 10(7)
Subject
Language
ISSN
2405-8440